Home
HelpTest Code 2C19 Cytochrome P450 2C19 (PLAVIX®) Genotype, Blood
Methodology
The eSensor® 2C19 Test uses a solid-phase electrochemical method for determining the CYP2C19 mutation status of a defined panel of CYP2C19 mutations.
This test confirms the presence of genotypes that affect the metabolism of drugs, such as PLAVIX®, that are metabolized by cytochrome CYP2C19.
Specimen Requirements
Container/Tube: Lavender-top (EDTA) tube(s)
Specimen Volume: 3 mL (minimum volume: 1 mL) of whole blood
Collection Instructions: Do not centrifuge.
Day(s) Test Set Up
Monday through Friday
Reference Values
2C19 *1/*1
Performing Laboratory
Logan Health Medical Center Laboratory
Test Classification and CPT Coding
Test Classification:
This test was developed and its performance characteristics determined by Logan Health Medical Center, Kalispell, MT. It has not been cleared or approved by the U.S. Food and Drug Administration.
CPT Code:
83891-Extraction
83892-Enzymatic digestion
83900-Amplification, target, multiplex, first 2 nucleic acid
sequences
83901 x 9-Amplification, target, multiplex, each additional nucleic
acid sequence beyond 2
88384-Array-based evaluation, 11 to 50 probes
Specimen Transport Temperature
Ambient/Refrigerate OK